Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheinberg

Showing results (361-370 of 426) with videos related to

Pageof 43
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2016
Remodeling the Vascular Microenvironment of Glioblastoma with α-ParticlesKatja Behling, William F Maguire, Valentina Di Gialleonardo, et al.
Cancer Immunology Research|March 19, 2020
Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic PlatformRon S Gejman, Heather F Jones, Martin G Klatt, et al.
Science (New York, N.Y.)|November 17, 2001
Tumor therapy with targeted atomic nanogeneratorsM R McDevitt, D Ma, L T Lai, et al.
The New England Journal of Medicine|November 5, 1998
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxideS L Soignet, P Maslak, Z G Wang, et al.
Blood|November 5, 2005
Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease modelBarry J Kappel, Javier Pinilla-Ibarz, Adam A Kochman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2003
Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGelHatice Duzkale, Lance C Pagliaro, Michael G Rosenblum, et al.
Bone Marrow Transplantation|September 4, 2003
Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemiasJ M Burke, P C Caron, E B Papadopoulos, et al.
The Journal of Clinical Investigation|June 20, 2017
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigensAaron Y Chang, Tao Dao, Ron S Gejman, et al.
The Journal of Clinical Investigation|September 2, 2017
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigensAaron Y Chang, Tao Dao, Ron S Gejman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responsesNicole Lamanna, Joseph G Jurcic, Ariela Noy, et al.
Pageof 43

Showing results (361-370 of 426) with videos related to

Sort By:
Pageof 43
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2016
Remodeling the Vascular Microenvironment of Glioblastoma with α-ParticlesKatja Behling, William F Maguire, Valentina Di Gialleonardo, et al.
Cancer Immunology Research|March 19, 2020
Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic PlatformRon S Gejman, Heather F Jones, Martin G Klatt, et al.
Science (New York, N.Y.)|November 17, 2001
Tumor therapy with targeted atomic nanogeneratorsM R McDevitt, D Ma, L T Lai, et al.
The New England Journal of Medicine|November 5, 1998
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxideS L Soignet, P Maslak, Z G Wang, et al.
Blood|November 5, 2005
Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease modelBarry J Kappel, Javier Pinilla-Ibarz, Adam A Kochman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2003
Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGelHatice Duzkale, Lance C Pagliaro, Michael G Rosenblum, et al.
Bone Marrow Transplantation|September 4, 2003
Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemiasJ M Burke, P C Caron, E B Papadopoulos, et al.
The Journal of Clinical Investigation|June 20, 2017
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigensAaron Y Chang, Tao Dao, Ron S Gejman, et al.
The Journal of Clinical Investigation|September 2, 2017
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigensAaron Y Chang, Tao Dao, Ron S Gejman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responsesNicole Lamanna, Joseph G Jurcic, Ariela Noy, et al.
Pageof 43